Literature DB >> 1969368

Oral contraceptives, insulin resistance and ischemic vascular disease.

E Eschwége1, A Fontbonne, D Simon, N Thibult, B Balkau, M Saint-Paul, P Garnier, C Senan, L Papoz.   

Abstract

From a large prospective study on diabetes risks, 1112 professionally active, non-menopausal, non-pregnant, healthy women were cross-sectionally analysed according to their use of oral contraception. After adjustment for age, weight and diabetes risk factors, those taking the pill, compared to those who did not, had significantly higher fasting serum insulin, triglycerides and 2-h 75 g OGTT blood glucose levels. The insulin-resistance markers which have recently been cited as ischemic vascular disease risk factors should be carefully monitored in pill users.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1969368     DOI: 10.1016/0020-7292(90)91021-h

Source DB:  PubMed          Journal:  Int J Gynaecol Obstet        ISSN: 0020-7292            Impact factor:   3.561


  4 in total

Review 1.  Drug-induced disorders of glucose metabolism. Mechanisms and management.

Authors:  J C Chan; C S Cockram; J A Critchley
Journal:  Drug Saf       Date:  1996-08       Impact factor: 5.606

2.  Oral contraceptive use and the risk of type 2 (non-insulin-dependent) diabetes mellitus in a large prospective study of women.

Authors:  E B Rimm; J E Manson; M J Stampfer; G A Colditz; W C Willett; B Rosner; C H Hennekens; F E Speizer
Journal:  Diabetologia       Date:  1992-10       Impact factor: 10.122

3.  Epidemiological features of glycated haemoglobin A1c-distribution in a healthy population. The Telecom Study.

Authors:  D Simon; C Senan; P Garnier; M Saint-Paul; L Papoz
Journal:  Diabetologia       Date:  1989-12       Impact factor: 10.122

4.  Association between contraceptive use and gestational diabetes: Missouri Pregnancy Risk Assessment Monitoring System, 2007-2008.

Authors:  Brittney A Kramer; Jeremy Kintzel; Venkata Garikapaty
Journal:  Prev Chronic Dis       Date:  2014-07-17       Impact factor: 2.830

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.